Due to successful results in the first phase of our study on the effects of our Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project.
Testing our products to prove clinical efficacy is one of our core values, and something that sets us apart in the industry. Due to successful results in the first phase of our study on the effects of our Lycored Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project. The results of the study showed that subjects who ingested our blend had significantly reduced systolic and diastolic blood pressures and increased retinal capillary blood flow markers. Professor Alon Harris, principal clinical study investigator, believes that “these initial results of the […] study showcase the importance of the development of supplements for eyes and where the future of the vision health industry is heading.” We hope to keep the promising results coming, and we’re excited to see what phase two brings.
Sodium and added sugar reduction that meets consumer expectations Sodium and added sugar reduction are top of mind for many consumers seeking better-for-you food options. 44% of Americans reported trying...
Thanks for making IFT FIRST a success! It was a pleasure connecting with customers, partners, and fellow innovators on the expo hall floor. Our team was proud to showcase why...
Nature Never Fades and Neither Should Your Color IFT FIRST is just around the corner and Lycored is bringing nature’s lasting power to the expo floor. At Lycored, we’re grounded...
Interested in speaking directly with a member of our team?
Click below to get in touch.